Horizons Marijuana Life Sciences ETF (HMMJ.TO)
10.53
-0.07
(-0.66%)
CAD |
TSX |
Mar 23, 16:00
Key Stats
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.86% | 0.26% | 106.44M | 8337.93 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 2.50% | 86.60% | -15.66M | Upgrade |
Basic Info
| Investment Strategy | |
| HMMJ seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The North American Marijuana Index is designed to provide exposure to the performance of a basket of North American publicly listed companies with significant business activities in the marijuana industry. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Sector Equity |
| Category Index | Morningstar Gbl GR CAD |
| Global Category Name | Equity Miscellaneous |
| YCharts Categorization | Other |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Horizons ETFs Management (Canada) Inc |
| Prospectus Benchmark Index | |
| NORTH AMERICAN MARIJUANA TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Not Disclosed | 5.91 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
79
-15.66M
-120.22M
Category Low
464.45M
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of February 28, 2023
Risk
Performance Versus Category
As of March 22, 2023. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of March 22, 2023.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Jazz Pharmaceuticals PLC | 17.29% | 137.45 | -0.73% |
| The Scotts Miracle Gro Co A | 14.51% | 67.40 | -4.56% |
| Innovative Industrial Properties Inc Registered Shs | 12.78% | 74.13 | -1.50% |
| Cronos Group Inc | 11.63% | 2.62 | 1.55% |
| Tilray Brands Inc | 10.80% | 2.61 | 1.56% |
| Canopy Growth Corp | 8.84% | 2.62 | 1.16% |
| Constellation Brands Inc Class A | 5.85% | 214.99 | 0.40% |
| SNDL Inc Ordinary Shares | 3.27% | 1.54 | 2.67% |
| OrganiGram Holdings Inc | 2.56% | 0.87 | 1.16% |
| Alimentation Couche-Tard Inc | 1.62% | 63.97 | 0.77% |
News
Headline
Wire
Time (ET)
MT Newswires
03/23 16:55
MT Newswires
03/23 16:41
MT Newswires
03/23 06:32
MT Newswires
03/23 06:31
MT Newswires
03/22 08:56
MT Newswires
03/22 08:33
MT Newswires
03/21 08:03
MT Newswires
03/21 07:31
Basic Info
| Investment Strategy | |
| HMMJ seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The North American Marijuana Index is designed to provide exposure to the performance of a basket of North American publicly listed companies with significant business activities in the marijuana industry. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Sector Equity |
| Category Index | Morningstar Gbl GR CAD |
| Global Category Name | Equity Miscellaneous |
| YCharts Categorization | Other |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Horizons ETFs Management (Canada) Inc |
| Prospectus Benchmark Index | |
| NORTH AMERICAN MARIJUANA TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Not Disclosed | 5.91 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (3-23-23) | 2.50% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of February 28, 2023
Fund Details
| Key Dates | |
| Inception Date | 4/4/2017 |
| Last Annual Report Date | 12/31/2021 |
| Last Prospectus Date | 6/27/2022 |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
MT Newswires
03/23 16:55
MT Newswires
03/23 16:41
MT Newswires
03/23 06:32
MT Newswires
03/23 06:31
MT Newswires
03/22 08:56
MT Newswires
03/22 08:33
MT Newswires
03/21 08:03
MT Newswires
03/21 07:31